(PLXS) Plexus - Overview

Sector: Technology | Industry: Electronic Components | Exchange: NASDAQ (USA) | Market Cap: 6.915m USD | Total Return: 94.7% in 12m

Circuit Boards, Electronics Manufacturing, Design Engineering, Supply Chain
Total Rating 66
Safety 87
Buy Signal 1.48
Electronic Components
Industry Rotation: -6.5
Market Cap: 6.91B
Avg Turnover: 83.9M
Risk 3d forecast
Volatility32.2%
VaR 5th Pctl5.13%
VaR vs Median-3.63%
Reward TTM
Sharpe Ratio1.80
Rel. Str. IBD92.9
Rel. Str. Peer Group50
Character TTM
Beta1.092
Beta Downside1.156
Hurst Exponent0.416
Drawdowns 3y
Max DD34.92%
CAGR/Max DD1.27
CAGR/Mean DD4.38
EPS (Earnings per Share) EPS (Earnings per Share) of PLXS over the last years for every Quarter: "2021-03": 1.49, "2021-06": 0.99, "2021-09": 1.16, "2021-12": 0.88, "2022-03": 0.95, "2022-06": 1.33, "2022-09": 1.78, "2022-12": 1.49, "2023-03": 1.45, "2023-06": 1.32, "2023-09": 1.44, "2023-12": 1.04, "2024-03": 0.94, "2024-06": 1.45, "2024-09": 1.85, "2024-12": 1.73, "2025-03": 1.66, "2025-06": 1.9, "2025-09": 2.14, "2025-12": 1.78, "2026-03": 2.05,
EPS CAGR: 12.23%
EPS Trend: 53.8%
Last SUE: 1.58
Qual. Beats: 1
Revenue Revenue of PLXS over the last years for every Quarter: 2021-03: 880.885, 2021-06: 814.387, 2021-09: 843.238, 2021-12: 817.456, 2022-03: 888.723, 2022-06: 981.341, 2022-09: 1123.848, 2022-12: 1093.925, 2023-03: 1070.823, 2023-06: 1021.61, 2023-09: 1023.947, 2023-12: 982.607, 2024-03: 966.9, 2024-06: 960.751, 2024-09: 1050.569, 2024-12: 976.122, 2025-03: 980.17, 2025-06: 1018.308, 2025-09: 1058.366, 2025-12: 1069.852, 2026-03: 1163.757,
Rev. CAGR: 4.65%
Rev. Trend: 9.3%
Last SUE: 1.77
Qual. Beats: 1

Warnings

No concerns identified

Tailwinds

Supp Ema20, Leader, Tailwind, Pullback 52w, Confidence

Description: PLXS Plexus

Plexus Corp (PLXS) is a global provider of electronic manufacturing services (EMS) specializing in the design, development, and production of complex electronic products. Headquartered in Wisconsin, the company operates across the United States, Asia-Pacific, and EMEA regions. Its business model focuses on mid-to-low volume, higher complexity programs, which typically command higher margins than high-volume consumer electronics manufacturing.

The company serves highly regulated end markets, including healthcare, life sciences, and aerospace/defense. This sector exposure provides a degree of insulation from cyclical consumer spending, as these industries often involve long product lifecycles and stringent certification requirements. Investors can explore historical valuation trends for the company on ValueRay. Plexus integrates supply chain management and sustaining services to support products from initial conceptualization through end-of-life support.

Headlines to Watch Out For
  • Aerospace and defense sector growth drives high-margin backlog expansion
  • Healthcare and life sciences product demand stabilizes long-term revenue streams
  • Inventory management and supply chain efficiency influence quarterly operating margins
  • New product introductions in industrial markets accelerate organic revenue growth
  • Global manufacturing footprint exposure affects operational costs and tax liabilities
Piotroski VR‑10 (Strict) 4.5
Net Income: 187.5m TTM > 0 and > 6% of Revenue
FCF/TA: 0.02 > 0.02 and ΔFCF/TA -9.14 > 1.0
NWC/Revenue: 21.46% < 20% (prev 20.93%; Δ 0.53% < -1%)
CFO/TA 0.05 > 3% & CFO 172.0m > Net Income 187.5m
Net Debt (-43.2m) to EBITDA (259.0m): -0.17 < 3
Current Ratio: 1.54 > 1.5 & < 3
Outstanding Shares: last quarter (27.4m) vs 12m ago -1.06% < -2%
Gross Margin: 10.05% > 18% (prev 0.10%; Δ 995.4% > 0.5%)
Asset Turnover: 133.7% > 50% (prev 128.6%; Δ 5.14% > 0%)
Interest Coverage Ratio: 9.30 > 6 (EBITDA TTM 259.0m / Interest Expense TTM 11.2m)
Altman Z'' 5.23
A: 0.28 (Total Current Assets 2.64b - Total Current Liabilities 1.71b) / Total Assets 3.36b
B: 0.62 (Retained Earnings 2.09b / Total Assets 3.36b)
C: 0.03 (EBIT TTM 104.4m / Avg Total Assets 3.22b)
D: 1.12 (Book Value of Equity 2.10b / Total Liabilities 1.87b)
Altman-Z'' Score: 5.23 = AAA
Beneish M -3.01
DSRI: 0.87 (Receivables 702.3m/745.6m, Revenue 4.31b/3.97b)
GMI: 1.00 (GM 10.05% / 10.10%)
AQI: 1.09 (AQ_t 0.04 / AQ_t-1 0.03)
SGI: 1.09 (Revenue 4.31b / 3.97b)
TATA: 0.00 (NI 187.5m - CFO 172.0m) / TA 3.36b)
Beneish M-Score: -3.01 (Cap -4..+1) = AA
What is the price of PLXS shares? As of May 19, 2026, the stock is trading at USD 258.87 with a total of 235,006 shares traded.
Over the past week, the price has changed by -4.75%, over one month by +8.80%, over three months by +31.26% and over the past year by +94.71%.
Is PLXS a buy, sell or hold? Plexus has received a consensus analysts rating of 3.80. Therefor, it is recommend to hold PLXS.
  • StrongBuy: 1
  • Buy: 2
  • Hold: 2
  • Sell: 0
  • StrongSell: 0
What are the forecasts/targets for the PLXS price?
Analysts Target Price 274.5 6%
Plexus (PLXS) - Fundamental Data Overview as of 16 May 2026
P/E Trailing = 37.893
P/E Forward = 32.7869
P/S = 1.6042
P/B = 4.7872
P/EG = 2.0859
Revenue TTM = 4.31b USD
EBIT TTM = 104.4m USD
EBITDA TTM = 259.0m USD
Long Term Debt = 92.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = 143.1m USD (from shortTermDebt, last quarter)
Debt = 259.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -43.2m USD (from netDebt column, last quarter)
Enterprise Value = 6.87b USD (6.91b + Debt 259.9m - CCE 303.1m)
Interest Coverage Ratio = 9.30 (Ebit TTM 104.4m / Interest Expense TTM 11.2m)
EV/FCF = 90.66x (Enterprise Value 6.87b / FCF TTM 75.8m)
FCF Yield = 1.10% (FCF TTM 75.8m / Enterprise Value 6.87b)
FCF Margin = 1.76% (FCF TTM 75.8m / Revenue TTM 4.31b)
Net Margin = 4.35% (Net Income TTM 187.5m / Revenue TTM 4.31b)
Gross Margin = 10.05% ((Revenue TTM 4.31b - Cost of Revenue TTM 3.88b) / Revenue TTM)
Gross Margin QoQ = 10.24% (prev 9.92%)
Tobins Q-Ratio = 2.04 (Enterprise Value 6.87b / Total Assets 3.36b)
Interest Expense / Debt = 1.32% (Interest Expense 3.42m / Debt 259.9m)
Taxrate = 13.94% (8.07m / 57.9m)
NOPAT = 89.9m (EBIT 104.4m * (1 - 13.94%))
Current Ratio = 1.54 (Total Current Assets 2.64b / Total Current Liabilities 1.71b)
Debt / Equity = 0.17 (Debt 259.9m / totalStockholderEquity, last quarter 1.49b)
Debt / EBITDA = -0.17 (Net Debt -43.2m / EBITDA 259.0m)
Debt / FCF = -0.57 (Net Debt -43.2m / FCF TTM 75.8m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.82% (Net Income 187.5m / Total Assets 3.36b)
RoE = 12.83% (Net Income TTM 187.5m / Total Stockholder Equity 1.46b)
RoCE = 6.72% (EBIT 104.4m / Capital Employed (Equity 1.46b + L.T.Debt 92.0m))
RoIC = 5.62% (NOPAT 89.9m / Invested Capital 1.60b)
WACC = 9.51% (E(6.91b)/V(7.17b) * Re(9.82%) + D(259.9m)/V(7.17b) * Rd(1.32%) * (1-Tc(0.14)))
Discount Rate = 9.82% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.11 | Cagr: -1.03%
[DCF] Terminal Value 64.14% ; FCFF base≈186.1m ; Y1≈122.2m ; Y5≈55.9m
[DCF] Fair Price = 34.36 (EV 876.1m - Net Debt -43.2m = Equity 919.4m / Shares 26.8m; r=9.51% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 53.85 | EPS CAGR: 12.23% | SUE: 1.58 | # QB: 1
Revenue Correlation: 9.32 | Revenue CAGR: 4.65% | SUE: 1.77 | # QB: 1
EPS current Quarter (2026-06-30): EPS=2.13 | Chg30d=+7.44% | Revisions=+50% | Analysts=5
EPS current Year (2026-09-30): EPS=8.21 | Chg30d=+6.72% | Revisions=+50% | GrowthEPS=+10.5% | GrowthRev=+17.1%
EPS next Year (2027-09-30): EPS=9.42 | Chg30d=+9.22% | Revisions=+56% | GrowthEPS=+14.7% | GrowthRev=+10.4%
[Analyst] Revisions Ratio: +56%